Like PAREXEL International Corporation

announced 6/20/2017 via Company Press Release

Pamplona Capital Management LLP, will acquire PAREXEL International Corporation

synopsis: Pamplona Capital Management, LLP has entered into a definitive agreement to acquire all of the outstanding shares of PAREXEL International Corporation, a leading global biopharmaceutical services provider. PAREXEL provides a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services.
buyer: Pamplona Capital Management LLP
Pamplona Capital Management is a London, New York, and Boston-based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds, and single-manager hedge fund investments. "
target: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.
price ($mm)[EV]
$4,508 [$4,923]
rev ($mm)
$2,097
EBITDA ($mm)
$343
EV / rev
2.4x
EV / EBITDA
14.6x
announced 9/25/2017 via BusinessWire

Konica Minolta, Inc., will acquire Invicro, LLC

synopsis: Konica Minolta, Inc. and Boston-based Invicro LLC announced that they have concluded an agreement whereby Konica Minolta will acquire Invicro, a leading provider of imaging services and software for research and drug development.
buyer: Konica Minolta, Inc. (TSE:4902:$9,557.68)
Konica Minolta, Inc. is a Japanese technology company headquartered in Tokyo. The company manufactures business and industrial imaging products, including copiers, laser printers, multi-functional peripherals (MFPs) and digital print systems for the production printing market. "
target: Invicro, LLC
Invicro is a leading provider of imaging services and software for research and drug development. Headquartered in Boston, Massachusetts, Invicro LLC was founded in 2008 with the mission of improving the role and function of imaging in drug discovery and development across all therapeutic areas.
price ($mm)
rev ($mm)
$106
EBITDA ($mm)
$17
EV / rev
0.0x
EV / EBITDA
0.0x
closed 8/16/2017 via BusinessWire

Evotec BioSystems GmbH, acquired Aptuit, Inc.

synopsis: Evotec announced that it has successfully completed the acquisition of Aptuit, a partner research organisation for integrated outsourced drug discovery and development solutions. This acquisition adds considerable business opportunities to further accelerate Evotec's long-term strategy to be the industry partner of choice for external innovation.
buyer: Evotec BioSystems GmbH (XTRA:EVT:$226.46)
Founded in Hamburg Germany, Evotec BioSystems GmbH is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. "
target parent: Welsh, Carson, Anderson & Stowe
target: Aptuit, Inc.
Aptuit, Inc. (formerly Global Pharmaceutical Development, Inc.) is an emerging company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators.
price ($mm)
$300
rev ($mm)
$93
EBITDA ($mm)
$12
EV / rev
3.2x
EV / EBITDA
25.8x
announced 5/10/2017 via BNC Analysis

inVentiv Health, Inc. will be merged with INC Research, Inc.,

synopsis: INC Research Holdings, Inc., a leading global Phase I-IV Contract Research Organization ("CRO"), and inVentiv Health, Inc., a leading, global CRO and Contract Commercial Organization will merge. INC Research shareholders will own approximately 53 percent and inVentiv shareholders will own approximately 47 percent of the merged entity.
buyer: INC Research, Inc. (SYNH:$3,472.40)
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. "
target parent: Thomas H. Lee Partners, L.P.
target: inVentiv Health, Inc.
inVentiv Health is a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market. Their Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) offer a differentiated suite of services.
price ($mm)[EV]
$2,453 [$4,552]
rev ($mm)
$2,156
EBITDA ($mm)
$306
EV / rev
2.1x
EV / EBITDA
14.9x
closed 10/3/2016 via BusinessWire

Quintiles Transnational Corp. merged with IMS Health Incorporated,

synopsis: Quintiles IMS Holdings, Inc. announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. The merger creates a leading information and tech-enabled global healthcare service provider, and a full suite of end-to-end clinical and commercial offerings.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. They help customers navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes.
price ($mm)
$8,750
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2009 via BusinessWire

PPD, Inc., acquired Excel PharmaStudies Inc.

synopsis: PPD, Inc. announced it has completed its acquisition of Excel PharmaStudies, Inc., one of the largest contract research organizations in China. The acquisition strengthens PPD’s full range of drug development services in the country and positions it to capitalize on the tremendous growth of the outsourcing market in Asia Pacific.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: Excel PharmaStudies Inc.
Excel PharmaStudies, Inc. is a full-service provider of clinical research, registration, biometrics, and training and consultation services. Excel is the leading CRO in China and operates 22 offices worldwide, with more than 300 staff members.
price ($mm)
$16
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2009 via PR Newswire

Pierrel SpA, purchased US Operations from Encorium Group Inc.

synopsis: Encorium Group, Inc., a full service multinational clinical research organization, announced that is has completed the previously announced sale of the Company's U.S. business to Pierrel Research USA, Inc., a wholly-owned subsidiary of Pierrel SpA, an international contract research organization listed on Milano's Stock Exchange.
buyer: Pierrel SpA (PIELF:$0.00)
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use. "
seller: Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
price ($mm)[EV]
$0.08 [$2.58]
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/8/2009 via PR Newswire

Next Fuel, Inc., will acquire Clinical Trials of the Americas, Inc.

synopsis: Clinical Trials of America Inc. announced that it has entered into a binding letter of intent to sell shares equal to approximately 75% of its issued and outstanding shares to Next Fuel Inc., a developer of a proprietary "On Demand" Hydrogen Generation System.
buyer: Next Fuel, Inc.
Next Fuel Inc. is a developer of a proprietary "On Demand" Hydrogen Generation System that is used as fuel for Fuel Cells which produce electricity. "
target: Clinical Trials of the Americas, Inc.
Clinical Trials of the Americas, Inc. provides clinical trial investigator services in dedicated sites throughout the Americas. Initially, we intend to introduce our services in Central America.
price ($mm)
$0.29*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/2/2009 via PR Newswire

ASG, Inc., acquired Ockham Development Group, Inc.

synopsis: ASG, Inc. a high-quality functional outsourcing and specialty staffing services group based in Cary, North Carolina - has acquired neighboring Ockham Development Group, Inc., a full-service contract research organization.
buyer: ASG, Inc.
ASG provides high-quality functional outsourcing and specialty staffing services to CROs, pharmaceutical, biotech and medical device companies that require clinical operations, GCP, GLP or GMP auditing, data management, statistical programming, biostatistics and medical writing solutions. "
target: Ockham Development Group, Inc.
Ockham Development Group Inc. is a privately held contract research organization headquartered in Cary, North Carolina.
price ($mm)
rev ($mm)
$12
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 4/22/2009 via BusinessWire

PPD, Inc., acquired AbCRO, Inc.

synopsis: PPD, Inc. announced that it has completed the acquisition of AbC.R.O., Inc., a Bulgarian contract research organization. The acquisition strengthens PPD’s ability to provide a broad range of clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs services to its growing client base in the Balkans.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: AbCRO, Inc.
AbCRO provides a full range of Phase II-IV clinical services, including clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs.
price ($mm)
$36
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/20/2009 via PR Newswire

PharmaNet Development Group, Inc. merged with JLL Partners,

synopsis: JLL Partners, a leading private equity investment fund, and PharmaNet Development Group, Inc., a leading provider of clinical development services, announced the successful completion of the tender offer by JLL PharmaNet Holdings, LLC.
buyer: JLL Partners
Founded in 1988, JLL Partners is among the leading private equity investment firms in the country. Since inception, we have managed a series of private equity funds aggregating approximately $4 billion in committed capital. "
target: PharmaNet Development Group, Inc.
PharmaNet Development Group, Inc. is a leader in outsourced clinical development that offers clinical-development solutions including early and late stage consulting services, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs.
price ($mm)[EV]
$101 [$186]
rev ($mm)
$451
EBITDA ($mm)
$26
EV / rev
0.4x
EV / EBITDA
7.1x
closed 1/27/2009 via BusinessWire

Altarum Institute, acquired KAI Research, Inc.

synopsis: Altarum Institute, a non-profit health systems research and consulting organization, has purchased Rockville, Maryland-based KAI Research, Inc. (KAI). KAI provides innovative, cost-effective and practical support to the pharmaceutical and biotech industry, academic institutions and the National Institutes of Health.
buyer: Altarum Institute
Altarum Institute is a nonprofit health systems research and consulting organization serving government and private-sector clients. "
target: KAI Research, Inc.
KAI Research provides innovative, cost-effective and practical support to the pharmaceutical and biotech industries. KAI currently supports pharmaco-vigilance activities for over 90 marketed drugs and is providing safety surveillance for dozens of ongoing clinical trials.
price ($mm)
$7.55
rev ($mm)
$10
EBITDA ($mm)
EV / rev
0.8x
EV / EBITDA
closed 3/13/2009 via BNC Analysis

Premier Research Group, acquired Pivotal Research Centers, LLC

synopsis: PHC, Inc. d/b/a Pioneer Behavioral Health, a leading provider of inpatient and outpatient behavioral health services, announced Premier Research Arizona, LLC, a unit of Premier Research Group PLC, has signed a purchase agreement to acquire the assets of PHC's Pivotal Research Centers.
buyer: Premier Research Group
Premier Research is a leading solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. "
target parent: Pioneer Behavioral Health
target: Pivotal Research Centers, LLC
Pivotal Research Centers, LLC provides clinical drug testing. It performs all phases of clinical research for Phase I to Phase IV drugs under development through two research sites. Pivotal was founded by Louis C. Kirby in 1993 and is based in Phoenix, Arizona.
price ($mm)
$3.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/30/2007 via Company Press Release

Chiltern International Inc., acquired Clinical Trial Management Services, Inc.

synopsis: Chiltern, a leading global clinical research organization (CRO), announced the acquisition of Clinical Trial Management Services, Inc. (CTMS) a Bristol, Tennessee based CRO offering high quality services throughout the United States.
buyer: Chiltern International Inc.
Chiltern is a global CRO with experience running and staffing international Phase I to Phase IV clinical trials. Chiltern’s services include: Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. "
target: Clinical Trial Management Services, Inc.
Clinical Trial Management Services, Inc. provides clinical research services such as clinical trial management and monitoring services, such as project management, investigative site management and monitoring services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/14/2009 via BusinessWire

NexMed, Inc., acquired Bio-Quant, Inc.

synopsis: NexMed, Inc., a developer of products based on the NexACT® technology, announced the closing of its acquisition of Bio-Quant, Inc., a privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA.
buyer: NexMed, Inc. (NEXM:$0.00)
NexMed is an innovative drug developer that is leveraging its proprietary NexACT® drug delivery technology to produce a host of new medical treatments. NexMed’s drugs address a variety of health conditions, such as nail fungus, sexual disorders and more. "
target: Bio-Quant, Inc.
Founded in 1999, Bio-Quant is the largest specialty CRO based in San Diego and is one of the industry's most experienced CROs for in vitro and in vivo pharmacology services and research models specializing in oncology, inflammation, immunology, and metabolic diseases, including diabetes.
price ($mm)[EV]
$13 [$13]
rev ($mm)
$5
EBITDA ($mm)
EV / rev
2.5x
EV / EBITDA
announced 10/28/2009 via PR Newswire

Alpha Analytical, will acquire Boston Analytical

synopsis: Alpha Analytical is announcing the completion of the acquisition of Boston Analytical, Inc. Established in 1987, Boston Analytical is a registered, cGMP compliant contract testing laboratory providing quality analytical and microbiological testing services to the pharmaceutical, biotech, device, cosmetic and nutritional product industries.
buyer: Alpha Analytical
Alpha Analytical, Inc. provides full-service environmental laboratory solutions for the most demanding industrial and commercial applications in the U.S. and abroad. Alpha Analytical is the largest environmental laboratory in New England and among the top 18 laboratories in the country. "
target: Boston Analytical
Boston Analytical is committed to providing quality Analytical and Microbiological testing services to pharmaceutical companies worldwide in support of their Product Development, Release and Stability Testing objectives.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/12/2009 via Company Press Release

J O Hambro Capital Management Limited, acquired Celsis International

synopsis: Chicago-based Celsis International, a leading global life sciences company, announces that it has been acquired by UK-based private equity firm J O Hambro and will de-list from the London Stock Exchange (LSE) and operate as a privately held company.
buyer: J O Hambro Capital Management Limited
J O Hambro Capital Management, the London-based boutique investment firm, offers an alternative to the large traditional fund management firms that have dominated the market for many years. "
target: Celsis International
Celsis International plc is a leading international provider of innovative life science products and laboratory services to the pharmaceutical and consumer products industries through our three divisions: Rapid Detection, Analytical Services and In Vitro Technologies.
price ($mm)[EV]
$55 [$52]*
rev ($mm)
$42
EBITDA ($mm)
$12
EV / rev
1.9x
EV / EBITDA
6.3x
closed 7/16/2009 via PR Newswire

Water Street Healthcare Partners, acquired AAIPharma Services

synopsis: Water Street Healthcare Partners, a leading private equity firm focused exclusively on the health care industry, announced that it has acquired the Pharmaceutical Development division from AAIPharma Inc.
buyer: Water Street Healthcare Partners
Water Street Healthcare Partners is a leading private equity firm focused exclusively on health care. With more than $1 billion of capital under management, Water Street is one of the most active investors in the health care industry. "
target parent: AAIPharma Inc.
target: AAIPharma Services
AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies. Its team of 450 scientists and professionals specialize in services that encompass the entire process of pharmaceutical drug development from discovery through commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/1/2009 via Reuters

INC Research, Inc., will purchase Late Stage Research Unit from MDS, Inc.

synopsis: MDS Inc has announced that it planns to narrow its contract research focus by selling its late stage operations and central laboratory divisions to Contract Research Organization INC Research, Inc.
buyer: INC Research, Inc. (SYNH:$3,472.40)
INC Research is a therapeutically focused contract research organization with an unrivaled reputation for conducting Phase I- Phase IV clinical development programs of the highest integrity. "
seller: MDS, Inc. (MDZ:$231.00)
MDS Inc. is a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. The Company has more than 5,000 employees in 29 countries and net revenues of more than US$1.2 bil.
price ($mm)
$45
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2009 via PR Newswire

ChemRar High-Tech Center, acquired Prudentas, LLC

synopsis: ChemDiv, a global chemistry-driven contract research organization, announced that its ChemRar High Tech Center has acquired Prudentas LLC, one of the leading CRO companies conducting high quality Phase I - Phase IV studies in Eastern Europe.
buyer parent: ChemDiv, Inc.
buyer: ChemRar High-Tech Center
The ChemRar High-Tech Center is a unique pharma and biotechnology complex founded by innovative life science organizations in Russia. ChemRar's component companies are engaged in discovering, developing and commercializing novel drugs for partners in Russia and worldwide. "
target: Prudentas, LLC
Prudentas is a Russian Clinical Contract Research Organization founded by and consisting of highly qualified clinical research professionals with extensive experience of working previously together as a team.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/20/2017 via Company Press Release

Pamplona Capital Management LLP, will acquire PAREXEL International Corporation

synopsis: Pamplona Capital Management, LLP has entered into a definitive agreement to acquire all of the outstanding shares of PAREXEL International Corporation, a leading global biopharmaceutical services provider. PAREXEL provides a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services.
buyer: Pamplona Capital Management LLP
Pamplona Capital Management is a London, New York, and Boston-based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds, and single-manager hedge fund investments. "
target: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.
price ($mm)[EV]
$4,508 [$4,923]
rev ($mm)
$2,097
EBITDA ($mm)
$343
EV / rev
2.4x
EV / EBITDA
14.6x
closed 10/3/2014 via PR Newswire

PAREXEL International Corporation, acquired ClinIntel Ltd.

synopsis: PAREXEL International Corporation, a global clinical research organization, announced that the Company has acquired all of the outstanding equity securities of privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom.
buyer: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. "
target: ClinIntel Ltd.
Headquartered in the United Kingdom, ClinIntel is a provider of clinical Randomization and Trial Supply Management (RTSM) services. The company was founded in 2009, and works with biopharmaceutical companies and contract research organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/27/2012 via PR Newswire

PAREXEL International Corporation, acquired Liquent, Inc.

synopsis: PAREXEL International Corporation announced it acquired all of the outstanding equity securities of Liquent, Inc., a leading global provider of Regulatory Information Management solutions. Liquent provides an integrated platform of software solutions for regulatory submissions and product registration management.
buyer: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. "
target parent: Marlin Equity Partners
target: Liquent, Inc.
Liquent is the leading provider of innovative software and professional services designed to support the regulatory business processes of global life sciences companies. Over 200 companies of varying sizes and product portfolios have produced over 100,000 regulatory submissions using its software.
price ($mm)
$72
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/14/2008 via PR Newswire

PAREXEL International Corporation, acquired ClinPhone plc

synopsis: PAREXEL International Corporation, a leading global biopharmaceutical services organization, announced the successful closing of the acquisition of ClinPhone plc, a leading clinical technology organization.
buyer: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. "
target: ClinPhone plc
ClinPhone is the world’s leading Clinical Technology Organization (CTO) and their products consists of software and services, are practical, intuitive and user-friendly. Their products can fully integrate, providing one complete and reliable source for all of your clinical trial technology needs.
price ($mm)[EV]
$185 [$201]
rev ($mm)
$96
EBITDA ($mm)
$12
EV / rev
2.0x
EV / EBITDA
16.9x
closed 9/10/2002 via

synopsis: Perceptive Informatics, Inc. (Perceptive), a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), today announced the acquisition of Invantage, Inc., a software company based in Cambridge, Massachusetts.
buyer parent: PAREXEL International Corporation
buyer: Perceptive Informatics, Inc.
Perceptive Informatics, Inc. develops and offers a portfolio of sophisticated and innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales. The technology portfolio includes web-based portal solutions and tracking to "
target:
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/21/2019 via Company Press Release

BlackRock, Inc., acquired Cofense

synopsis: Cofense is pleased to announce that BlackRock Private Equity Partners is now their majority equity holder, having acquired the equity of former investor Pamplona. Cofense, formerly PhishMe, is the leading provider of human-driven phishing defense solutions world-wide.
buyer: BlackRock, Inc. (BLK:$13,880.00)
BlackRock is a global leader in investment management, risk management and advisory services for institutional & retail clients. BlackRock helps clients meet their goals with a range of products that include separate accounts, mutual funds, exchange-traded funds, & other pooled investment vehicles. "
target parent: Pamplona Capital Management LLP
target: Cofense
Cofense, formerly PhishMe, is the leading provider of human-driven phishing defense solutions world-wide. They deliver a collaborative approach to cybersecurity by enabling organization-wide engagement to active email threats.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/8/2018 via Company Press Release

GetWellNetwork, Inc., acquired HealthLoop

synopsis: GetWellNetwork, the Precision Engagement health care company, announced that it has acquired HealthLoop. HealthLoop is a leading digital health company with over 7.2 million annual patient interactions. Their cloud-based platform helps automate patient engagement and allows care teams to engage and identify patients in real-time.
buyer parent: Pamplona Capital Management LLP
buyer: GetWellNetwork, Inc.
GetWellNetwork is a Precision Engagement health care company. Their patient engagement solutions range from patient education to clinician tools. GetWellNetwork offers the only cross-continuum platform that performs across every care setting. "
target: HealthLoop
HealthLoop is a cloud-based platform that automates patient engagement follow-up care. Their automated daily check-ins enables care teams to engage patients and identifies the patients that need help in real-time, allowing care teams to intervene before costs and complications escalate.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/17/2018 via GlobeNewswire

Veritext Corp., acquired David Feldman Worldwide Court Reporting

synopsis: Veritext, the national leader in court reporting and litigation support solutions, announces its acquisition of David Feldman Worldwide (DFW) Court Reporting. DFW’s experience with very complex litigation cases and exemplary customer service complements Veritext’s full breadth of technical solutions and world-class data security.
buyer parent: Pamplona Capital Management LLP
buyer: Veritext Corp.
Veritext is the leader in deposition and litigation support solutions. They provide national coverage and skilled court reporters. Their solutions utilize the latest easy-to-use technologies that streamline the deposition process, enhance delivery flexibility and reliably handle complex cases. "
target: David Feldman Worldwide Court Reporting
David Feldman Worldwide (DFW) Court Reporting is one of the largest independently owned companies that provide premier court reporting and litigation support solutions. Their mission is to "create the WRITE experience" by making DFW the best court reporting company to work for in the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/20/2017 via Company Press Release

Pamplona Capital Management LLP, will acquire PAREXEL International Corporation

synopsis: Pamplona Capital Management, LLP has entered into a definitive agreement to acquire all of the outstanding shares of PAREXEL International Corporation, a leading global biopharmaceutical services provider. PAREXEL provides a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services.
buyer: Pamplona Capital Management LLP
Pamplona Capital Management is a London, New York, and Boston-based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds, and single-manager hedge fund investments. "
target: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.
price ($mm)[EV]
$4,508 [$4,923]
rev ($mm)
$2,097
EBITDA ($mm)
$343
EV / rev
2.4x
EV / EBITDA
14.6x
closed 3/29/2017 via Company Press Release

nThrive, acquired e4e Inc.

synopsis: nThrive,a provider of patient-to-payment healthcare solutions, advisory expertise, and analytics for health care organizations, has acquired e4e Healthcare Services. e4e is a healthcare services outsourcing company that provides IT-enabled and business process management services.
buyer parent: Pamplona Capital Management LLP
buyer: nThrive (MDAS:$764.22)
nThrive is built on a legacy of excellence. From patient-to-payment, they will provide all the technology, advisory expertise, services, analytics and education programs their clients will need to thrive in the communities they serve. "
target: e4e Inc.
e4e Inc., a healthcare services outsourcing company, provides IT-enabled and business process management services. The company offers provider solutions; and payer solutions that include claims management and admin, cost avoidance and audit, and medical record solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/22/2017 via PR Newswire

Pamplona Capital Management LLP, acquired Legacy.com, Inc.

synopsis: Pamplona Capital Management, a Boston-based specialist investment manager, has acquired a majority interest in Legacy.com, the leading provider of obituary-related products and services to newspapers, funeral homes, and more than 43 million monthly visitors across the globe.
buyer: Pamplona Capital Management LLP
Pamplona Capital Management is a London, New York, and Boston-based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds, and single-manager hedge fund investments. "
target parent: Great Hill Partners LLC
target: Legacy.com, Inc.
Legacy.com is an innovative technology company that is the online leader in the memorial and obituary market. Legacy.com collaborates with more than 1,500 newspaper and funeral home clients to provide ways for individuals to express condolences and share remembrances of loved ones.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/1/2016 via PR Newswire

MedAssets-Precyse, acquired Equation Consulting

synopsis: Equation, an innovator in financial and clinical healthcare analytics and consulting, is pleased to announce it has been acquired by MedAssets-Precyse. Equation is a Utah based healthcare analytics and consulting company. It provides healthcare organizations with the analytic tools and expertise to gain insights to improve healthcare delivery.
buyer parent: Pamplona Capital Management LLP
buyer: MedAssets-Precyse (MDAS:$764.22)
The combined MedAssets-Precyse enterprise is the leader in providing end-to-end revenue cycle services, technology and education solutions. The companies offer extensive capabilities to improve organizations' operational health, grow business and ultimately improve the quality of healthcare. "
target: Equation Consulting
Equation is a Utah based healthcare analytics and consulting company. Its cloud-based analytics platform, DataRiver provides hospitals, healthcare systems, and physician practice groups with financial and clinical visibility into their organization to improve care, increase quality, and reduce cost.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/15/2016 via BusinessWire

Vizient, Inc., purchased SCM and Sg2 Businesses from MedAssets Inc.

synopsis: Vizient, Inc. announces it has completed the acquisition of MedAssets’ Spend and Clinical Resource Management (SCM) segment, including Sg2, from Pamplona Capital Management. The combined organization represents the nation’s top hospitals and health systems, and they have delivered billions in savings to providers over the past two years alone.
buyer: Vizient, Inc.
Vizient, Inc., the largest member-owned health care company in the country, is dedicated to serving members and customers through innovative data-driven solutions, expertise and collaborative opportunities that lead to improved patient outcomes and lower costs. "
seller parent: Pamplona Capital Management LLP
seller: MedAssets Inc. (MDAS:$764.22)
MedAsset's SCM business and Sg2 are leading providers of health care business intelligence, market analytics, and clinical consulting services. Its experts and software analytic tools are used by over 1,400 hospitals, healthy systems, pharmaceutical companies and medical device companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/1/2016 via PR Newswire

Pamplona Capital Management LLP, acquired Veritext Corp.

synopsis: Pamplona Capital Management, a specialist investment manager that provides an alternative investment platform, has bought Veritext, the leader in deposition and litigation support services. Veritext provides law firms, Fortune 500 corporations and regulatory agencies with national coverage, facilities, advanced technology and client service.
buyer: Pamplona Capital Management LLP
Pamplona Capital Management is a specialist investment manager that provides an alternative investment platform across private equity, fund of hedge funds and single manager hedge fund investments. They manage assets for a variety of clients. "
target parent: Investcorp
target: Veritext Corp.
Veritext has the goal of providing superior services to the legal industry. With almost two decades of continued industry excellence, Veritext is the established leader in providing technology-driven deposition and litigation support services to law firms and corporations around the globe.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/27/2016 via Company Press Release

Pamplona Capital Management LLP, acquired MedAssets Inc.

synopsis: Pamplona Capital Management, a London and New York based specialist investment manager, is pleased to announce it has agreed to acquire MedAssets, a leading healthcare performance improvement company that serves four out of every five hospitals in the United States.
buyer: Pamplona Capital Management LLP
Pamplona Capital Management is a London and New York based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds and single manager hedge fund investments. "
target: MedAssets Inc. (MDAS:$764.22)
MedAssets is a healthcare performance improvement company focused on helping providers realize financial and operational gains. More than 4,400 hospitals and 122,000 non-acute healthcare providers currently use the company's evidence-based solutions, best practice processes and analytics.
price ($mm)[EV]
$1,969 [$2,766]
rev ($mm)
$764
EBITDA ($mm)
$218
EV / rev
3.6x
EV / EBITDA
12.7x
closed 1/27/2016 via Company Press Release

Pamplona Capital Management LLP, acquired Precyse

synopsis: Pamplona Capital Management is pleased to announce that it has acquired Precyse, a leader in Health Information Management services, education and technology, from Altaris Capital Partners and NewSpring Capital. Precyse empowers healthcare organizations to most effectively capture, organize, secure and analyze clinical data
buyer: Pamplona Capital Management LLP
Pamplona Capital Management is a London and New York based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds and single manager hedge fund investments. "
target parent: Altaris Capital Partners
target: Precyse
Precyse Solutions is the leader in driving peak performance within HIM departments of US health care facilities. Precyse's technologies and services support best practices in multiple areas including: remote and on-site coding, transcription, audit and education, consulting and management services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/30/2017 via BNC Analysis

Technische Werke Ludwigshafen AG, acquired WEBfactory GmbH

synopsis: Fidura Private Equity Fonds has sold their majority stake in the software company WEBfactory GmbH in Buchen (Odenwald) successfully to Technische Werke Ludwigshafen AG (TWL). WEBFactory provides standard software for the surveillance and control of machines and industrial systems and for the online analysis and assessment of production data.
buyer: Technische Werke Ludwigshafen AG
Technische Werke Ludwigshafen AG (TWL) is a local utility company based in Ludwigshafen am Rhein, Germany. TWL has for over 100 years supplied the city of Ludwigshafen with electricity, gas, refrigeration, water and district heating. "
target parent: Fidura Private Equity Fonds
target: WEBfactory GmbH
WEBfactory GmbH, headquartered in Baden-Württemberg, Buchen, provides standard software for the surveillance and control of machines and industrial systems and for the online analysis and assessment of production data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/28/2016 via Market Wire

N. Harris Computer Corporation, acquired iMDsoft

synopsis: Constellation Software Inc., announced its wholly-owned subsidiary N. Harris Computer Corporation has acquired all of the shares of I.M.D. Soft Limited a leading international clinical information systems software provider.
buyer parent: Constellation Software, Inc.
buyer: N. Harris Computer Corporation
Harris has focused on providing feature-rich and robust turnkey solutions to Public Sector, Schools, Utility, and Health Care agencies throughout North America. Harris’ focus is on creating long-term relationships with its customers and ensuring that it meets the changing needs of its customers. "
target parent: TPG Capital
target: iMDsoft
iMDsoft is a leading provider of proven clinical information systems worldwide. The Company’s products are designed to enhance quality of care for critically ill patients and improve financial performance for healthcare providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/9/2012 via PR Newswire

MetrixLab, acquired MarketTools Inc.

synopsis: MetrixLab, a global provider of online consumer research services, announced that it has acquired MarketTools Research Solutions Inc., a leader in services and software for market research, from TPG Growth. MarketTools is known for pioneering some of the first research technologies on the Internet.
buyer: MetrixLab
MetrixLab is a fast-growing global provider of online consumer research services. Its solutions are employed by over half of the Top 100 Global Brands such as Microsoft, Philips, Google and Heineken. The company is headquartered in Rotterdam, The Netherlands. "
target parent: TPG Capital
target: MarketTools Inc.
MarketTools is the leading provider of services and software for market research. Through the use of advanced respondent engagement techniques and comprehensive analytic tools, MarketTools helps clients innovate, optimize and execute programs that deliver high-value business impact.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/23/2019 via PR Newswire

Dynata, will acquire Reimagine Holdings Group

synopsis: Dynata, a global leader in first-party data and data services, announces it has reached an agreement to acquire Reimagine Holdings Group, a global leader in data creation and technology-enabled business intelligence headquartered in Westport, Connecticut.
buyer parent: Court Square Capital Partners
buyer: Dynata
Dynata is the premier global provider of data solutions and technology for consumer and B2B survey research. Dynata reaches participants in 90+ sample countries via internet, telephone, mobile/wireless and mixed-access offerings. "
target: Reimagine Holdings Group
Reimagine is a global leader in data creation for business intelligence, and has redefined the insights industry by acquiring and investing in growth-oriented, technology-enabled service companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/23/2018 via BNC Analysis

startup300 AG, acquired Pioneers.io

synopsis: startup300, an Austrian angel investor network and business accelerator, has acquired Pioneers.io, an international relationship builder in the tech and startup scene. Pioneers' flagship event, Pioneers Festival, brings together a global community of 2,500 founders, investors, and innovation executives to build partnerships and shape the future.
buyer: startup300 AG
startup300 is an Austrian angel investor network and business accelerator that offers their services to Austrian startups. The group consists of 142 angels and investors that help startups grow their businesses. They focus on startups that have scalable, innovative or disruptive business models. "
target: Pioneers.io
Pioneers.io is an international relationship builder in the tech and startup scene, offering events, consulting, and investment. Their Pioneers Festival event brings together a global community of 2,500 founders, investors, and innovation executives to build partnerships and shape the future.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/14/2017 via PR Newswire

The Shipyard, acquired TOMORRO\\\ LLC

synopsis: The Shipyard, an independent marketing firm, today announces the acquisition of TOMORRO\\\, an innovation consultancy led by marketing icon Jon Bond – combining the companies' strategic, creative and data-centric talents to address rising demand from businesses seeking to inoculate themselves against Disruption.
buyer: The Shipyard
The Shipyard is an independent marketing consultancy and the first "marketing engineering" firm. It is creating digital transformation for the world's most significant brands- where high velocity content creation meets big data, where competitive strategy meets creative and disruptive advertising. "
target: TOMORRO\\\ LLC
TOMORRO\\\ LLC is a consultancy designed to accelerate brand value through the adoption of the most forward-thinking marketing approaches and technologies. TOMORRO\\\ is an active investor and advisor in ad technology companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/31/2017 via BNC Analysis

Capiton AG, will acquire Gemaco N.V.

synopsis: Capiton has entered into an agreement on the acquisition of a majority stake in Gemaco Group with the current majority shareholder Saffelberg Investments. Gemaco Group based with its headquarters in Mechelen, Belgium is a leading provider of full-service merchandising and promotional marketing solutions for global industry.
buyer: Capiton AG
Capiton is an owner-managed financial investor that invests in large SMEs in Germany, Austria and Switzerland by means of MBOs and expansion financing. capiton's roots go back to the late 1970s. "
target parent: Saffelberg Investments
target: Gemaco N.V.
Gemaco Group based with its headquarters in Mechelen, Belgium is a leading provider of full-service merchandising and promotional marketing solutions for global industry and fast-moving consumer goods (FMCG) customers. The Group has 13 locations worldwide.
price ($mm)
rev ($mm)
$96
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 12/21/2016 via Company Press Release

New Hope Communications Inc., acquired Nutrition Capital Network

synopsis: New Hope, a company that helps suppliers, manufacturers & retailers bring healthy, organic & natural products to life, has acquired the assets of Nutrition Capital Network (NCN), a company that holds four annual investor meetings which focus on investment and acquisition opportunities in branded products, ingredients and technology.
buyer parent: Informa plc
buyer: New Hope Communications Inc.
New Hope Network is at the forefront of the healthy lifestyle products industry. With solutions for the complete supply chain from manufacturers, retailers/distributors and service providers, the network offers a robust portfolio of content, events, data, research and consultative services. "
target: Nutrition Capital Network
Nutrition Capital Network holds four annual investor meetings which focus on investment and acquisition opportunities in branded products, ingredients and technology. They facilitate financing for growing companies and introduce investors to the next generation of brands.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/3/2018 via PR Newswire

RMRM Holdings, Sound Point Capital Management, will acquire Relativity Media, LLC

synopsis: Relativity Media has agreed to sell all of its assets to UltraV Holdings LLC, a joint venture among funds managed by Sound Point Capital Management and RMRM Holdings. Relativity Media operates a portfolio of major studio quality film assets with the capabilities and infrastructure to produce and distribute high caliber, original content.
buyer: RMRM Holdings
buyer: Sound Point Capital Management
UltraV Holdings LLC is a joint venture among funds managed by Sound Point Capital Management, a New York-based asset management firm with approximately $17 billion of assets under management, and RMRM Holdings, which is led by David Robbins, Lex Miron and Larry Robbins. "
target: Relativity Media, LLC
Relativity Media operates a portfolio of major studio quality film assets with the capabilities and infrastructure to produce and distribute high caliber, original content. They are engaged in the production and distribution of movies, television, fashion, sports, digital and music.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/4/2018 via PR Newswire

SilverLake, will acquire Weld North Education

synopsis: Silver Lake, the global leader in technology investing, announced that it will acquire a majority stake in Weld North Education (WNE), a leading digital education technology company focused on developing digital curriculum and tools for preK-12th grade, from KKR.
buyer: SilverLake
Silver Lake is the global leader in technology investing, with about $39 billion in combined assets under management and committed capital and a team of approximately 100 investment and value creation professionals located in Silicon Valley, New York, London, Hong Kong and Tokyo. "
target parent: Kohlberg Kravis Roberts & Co.
target: Weld North Education
Weld North Education operates a platform of digital and SaaS educational solution businesses and makes control investments in high potential businesses in the education industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/14/2017 via BNC Analysis

Boubyan Petrochemical Company, will acquire Educational Holding Group

synopsis: Boubyan Petrochemicals, the first private-sector company in Kuwait that invested in the government-controlled petrochemical sector, is to acquire majority stake in Educational Holding Group, the first private educational investments organization in Kuwait. Boubyan Petrochemicals is looking to buy 32.8% stake and currently hold 21.12% stake.
buyer: Boubyan Petrochemical Company (KWSE:BPCC:$93.42)
Boubyan Petrochemical Company K.S.C., a Kuwaiti shareholding company listed on the Kuwait Stock Exchange, is the first private-sector company in Kuwait that invested in the government-controlled petrochemical sector. The company was established on February 12, 1995 "
target: Educational Holding Group (KWSE:EDU:$38.04)
Founded in 1982, Educational Holding Group was the first private educational investments organization in Kuwait. The group has grown manifold with a portfolio that covers the entire educational life-cycle, ranging from K-12, tertiary education and vocational training and development.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/8/2005 via BusinessWire

eLocalAccess, LLC merged with TradeMaven Group LLC,

synopsis: TradeMaven LLC and eLocal today jointly announced they have merged the two firms to form TradeMaven Group LLC (TMG). The merger is one of the most significant in the online trading industry, combining TradeMaven's leading technology for online trading with eLocal's exceptional retail and institutional execution and brokerage services.
buyer: TradeMaven Group LLC
TradeMaven was founded with the mission of providing high-performance and cost-effective trading software for experienced and new traders. TM is used by Futures, Forex & Bond Traders worldwide. "
target: eLocalAccess, LLC
eLOCAL was established and registered with the NFA and CFTC in July 2000 culminating in the merger of two large independent local clearing firms at the Chicago Board of Trade.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/15/2009 via AP - Associated Press

Nordnet Bank AB, will acquire eQ Corporation

synopsis: Nordnet Bank AB has signed an agreement to acquire 100% of the shares in the Finnish company eQ, from Straumur Burdaras Investment Bank hf. eQ, the largest online-broker in Finland, has about 57 000 customer and the group specializes in investment services through three business areas; Securities Brokerage, Asset Management and Corporate Finance.
buyer: Nordnet Bank AB
The Nordnet Group provides user-friendly and cost efficient services to private investors and companies within share trading, mutual fund investments and pension savings plans. The holding company, Nordnet AB (plc), is listed on the Stockholm Stock Exchange. "
target parent: Straumur Burdaras Investment Bank, hf.
target: eQ Corporation
eQ, the largest online-broker in Finland, has about 57,000 customers and the group specializes in investment services through three business areas; Securities Brokerage, Asset Management and Corporate Finance.
price ($mm)
$51
rev ($mm)
$34
EBITDA ($mm)
EV / rev
1.5x
EV / EBITDA
announced 5/21/2009 via BusinessWire

PFGBEST, will acquire Alaron Futures & Options

synopsis: PFGBEST announced that it is purchasing the customer assets of Alaron. It will be formed into a new division called ATD, a division of PFGBEST. Both companies have been leaders in the futures industry for 20 years, through the evolution of online trading that helped level the playing field for retail futures market participants.
buyer: PFGBEST
PFGBEST is the second-largest non-clearing U.S. Futures Commission Merchant, with customers, affiliates and brokerage offices in more than 80 countries. It offers a range of trading and investor products and services for retail investors as well as for commercial and institutional clients. "
target: Alaron Futures & Options
Alaron, founded in 1989 in Chicago, provides electronic and pit-based futures trading and asset management services to institutions and retail clients on five continents. Alaron built upon its core business by integrating global trading systems and analysis techniques used by professional traders.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/15/2008 via PR Newswire

Lightspeed Professional Trading, LLC, acquired Integrity Trading Inc.

synopsis: Lightspeed Financial, LLC, announced that it has completed the acquisition of Integrity Trading Inc., a Direct Market Access broker/dealer that provides execution and clearing services to retail and institutional customers. Terms of the transaction were not disclosed.
buyer: Lightspeed Professional Trading, LLC
Lightspeed Professional Trading, LLC is a Direct Market Access trading and trading technology development business. Formerly E*TRADE Professional Trading, LLC, the firm was acquired by the current management team in a management buyout from E*TRADE Financial in 2006. "
target: Integrity Trading Inc.
Integrity Trading International is a broker dealer registered in the United States offering clearing and execution to U.S. and foreign banks, broker dealers and individuals interested in accessing the U.S. market and reselling our services in foreign countries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/21/2020 via BNC Analysis

SoFi, acquired 8 Securities Limited

synopsis: Consumer financial services platform SoFi has acquired 8 Securities, a Hong Kong-based investing app. Targeted to personal investors, 8 Securities will rebrand to SoFi Hong Kong and will begin launching services in other markets in addition to Hong Kong. 8 Securities was the first mobile-only investment service and robo-advisor to launch in Asia.
buyer: SoFi
SoFi is a values-driven company on a mission to help members get their money right. They create modern financial products and services that help people borrow, save, spend, invest, and protect their money better, so that they can achieve financial independence and realize their ambitions. "
target: 8 Securities Limited
Hong Kong-based 8 Securities is a cloud-based brokerage platform that provides simple, transparent, and affordable mobile investing solutions. The company allows users to trade over 15,000 US and Hong Kong stocks and exchange traded funds as much as they like free of commission.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/30/2020 via GlobeNewswire

Guardian Capital Group, will acquire ModernAdvisor

synopsis: Guardian Capital Group Limited, a Canadian diversified financial services company, will acquire Modern Advisor Canada Inc., a leading Canadian digital advisor platform. ModernAdvisor is a fintech start-up that helps investors to reach their investment goals through transparent, unbiased, and cost-effective investment management services.
buyer: Guardian Capital Group (TSX:GCG.A:$136.06)
Guardian Capital is a Canadian diversified financial services company operating in Asset Management and Financial Advisory. Guardian provides investment management services, financial advisory services, retail distribution of mutual funds, insurance, and general corporate services. "
target: ModernAdvisor
Vancouver-based ModernAdvisor is a digital investment management company. ModernAdvisor uses technology to help advisors bring Canadians intelligent investing options, allowing them to reach their investment goals through transparent, unbiased, and cost-effective investment management services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/2/2015 via BNC Analysis

Wealthsimple, will acquire ShareOwner

synopsis: Wealthsimple Financial Inc., Canada's leading online investing service, announced it has acquired Canadian ShareOwner Investments Inc., the country's first automated investment manager.
buyer: Wealthsimple
Wealthsimple is Canada's leading online investment manager, making smart and simple investing accessible to all Canadians with low minimums and low fees. Their on-demand financial planning services and investment advice educate clients and keep their investments on track. "
target: ShareOwner
ShareOwner (Canadian ShareOwner Investments) has been providing independent investment education and low-cost investing services to retail investors since 1987.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/3/2014 via BusinessWire

Evercore Partners Inc., acquired ISI Group, Inc.

synopsis: Evercore announced that it has acquired the operating businesses of ISI International Strategy & Investment (“ISI”). ISI is a leading independent research-driven equity sales and agency trading firm. ISI is a full service broker-dealer offering macro and fundamental research, sales and trading.
buyer: Evercore Partners Inc. (EVR:$1,004.73)
Evercore Partners is a leading independent investment banking advisory firm. Evercore’s Investment Banking business advises its clients on mergers, acquisitions, divestitures, restructurings, financings, public offerings, private placements and other strategic transactions. "
target: ISI Group, Inc.
ISI is a leading independent research-driven equity sales and agency trading firm. ISI strives to be the Street’s best investment research resource for their clients' money management performance. ISI is a full service broker-dealer offering macro and fundamental research, sales and trading.
price ($mm)
$132
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/1/2010 via BNC Analysis

FXCM Inc., acquired ODL Securities

synopsis: ODL Group Limited (“ODL”), a leading, independent forex, derivatives, equities and commodities broker, has been acquired by US-based FXCM Holdings LLC (“FXCM”), a leading global forex broker that caters to both retail and institutional markets.
buyer: FXCM Inc. (GLBR:$417.32)
FXCM Inc. is a global online provider of foreign exchange (forex) trading and related services to retail and institutional customers worldwide. Clients benefit from FXCM's large network of forex liquidity providers enabling FXCM to offer competitive spreads on major currency pairs. "
target: ODL Securities
ODL Securities Limited (ODLS) commenced trading early in 1995. Initially it specialised in derivatives and equities but recently has seen significant growth in foreign exchange, equity CFDs, Corporate and Government bond trading and other over-the-counter (OTC) products.
price ($mm)
$55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like PAREXEL International Corporation


read more

PAREXEL International Corporation

Invicro, LLC

Aptuit, Inc.

inVentiv Health, Inc.

Quintiles Transnational Corp.

Excel PharmaStudies Inc.

Encorium Group Inc.

Clinical Trials of the Americas, Inc.

Ockham Development Group, Inc.

AbCRO, Inc.

PharmaNet Development Group, Inc.

KAI Research, Inc.

Pivotal Research Centers, LLC

Clinical Trial Management Services, Inc.

Bio-Quant, Inc.

Boston Analytical

Celsis International

AAIPharma Services

MDS, Inc.

Prudentas, LLC

read more

PAREXEL International Corporation

ClinIntel Ltd.

Liquent, Inc.

ClinPhone plc

read more

Cofense

HealthLoop

David Feldman Worldwide Court Reporting

PAREXEL International Corporation

e4e Inc.

Legacy.com, Inc.

Equation Consulting

MedAssets Inc.

Veritext Corp.

MedAssets Inc.

Precyse

read more

WEBfactory GmbH

iMDsoft

MarketTools Inc.

Reimagine Holdings Group

Pioneers.io

TOMORRO\\\ LLC

Gemaco N.V.

Nutrition Capital Network

Relativity Media, LLC

Weld North Education

Educational Holding Group

eLocalAccess, LLC

eQ Corporation

Alaron Futures & Options

Integrity Trading Inc.

8 Securities Limited

ModernAdvisor

ShareOwner

ISI Group, Inc.

ODL Securities

Geography
Matching Companies
Ticker: SYNH
 
 
 
 
 
 
 
 
INC Research, Inc.
INC Research, Inc.
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries.
year
2018
rev ($mm)
$3,472.40
EBITDA ($mm)
$441.82
EBIT ($mm)
$157.52
Net Income ($mm)
Employees
21000
  • drill down
  • watch
Ticker: ICLR
 
 
 
 
 
 
 
 
ICON Plc
ICON Plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development.
year
2015
rev ($mm)
$1,541.91
EBITDA ($mm)
$289.74
EBIT ($mm)
$234.82
Net Income ($mm)
$192.14
Employees
11200
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
CMIC Co., Ltd.
CMIC is a leading full-service CRO in Japan offering a wide range of services in clinical trials in Asia to both multi-national and Japanese pharma companies.
year
2019
rev ($mm)
$664.65
EBITDA ($mm)
$76.21
EBIT ($mm)
$43.15
Net Income ($mm)
$23.12
Employees
4962
  • drill down
  • watch
Ticker: PIELF
 
 
 
 
 
 
 
 
Pierrel SpA
Pierrel SpA
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use.
year
2008
rev ($mm)
$64.38
EBITDA ($mm)
($4.23)
EBIT ($mm)
($8.92)
Net Income ($mm)
Employees
504
  • drill down
  • watch
Ticker: ENCO
 
 
 
 
 
 
 
 
Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
year
2008
rev ($mm)
$35.91
EBITDA ($mm)
($5.19)
EBIT ($mm)
($6.89)
Net Income ($mm)
Employees
226
  • drill down
  • watch
Ticker: ENXTPA:ERF
 
 
 
 
 
 
 
 
Eurofins Group
Eurofins Group
Based in Luxembourg, Eurofins is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments.
year
2017
rev ($mm)
$3,467.64
EBITDA ($mm)
$637.81
EBIT ($mm)
$406.82
Net Income ($mm)
$252.97
Employees
34651
  • drill down
  • watch
Ticker: CRL
 
 
 
 
 
 
 
 
Charles River Laboratories International Inc.
Charles River Laboratories International Inc.
Charles River has been helping our global partners accelerate drug discovery and development by providing them with tailored research models and preclinical, clinical, support services.
year
2009
rev ($mm)
$1,202.55
EBITDA ($mm)
$282.48
EBIT ($mm)
$188.93
Net Income ($mm)
$114.44
Employees
8000
  • drill down
  • watch
Ticker: LH
 
 
 
 
 
 
 
 
LabCorp
LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. LabCorp processes tests on approximately 470,000 specimens each day, applying advances in medicine and science to laboratory testing.
year
2009
rev ($mm)
$4,694.70
EBITDA ($mm)
$1,142.70
EBIT ($mm)
$949.40
Net Income ($mm)
$543.30
Employees
28000
  • drill down
  • watch
Ticker: KKR
 
 
 
 
 
 
 
 
Kohlberg Kravis Roberts & Co.
Kohlberg Kravis Roberts & Co.
KKR is a leading global investment firm that manages investments across multiple asset classes including private equity, energy, infrastructure, real estate, capital markets, credit strategies, and hedge funds. With offices around the world, KKR manages assets through a variety of investment funds.
year
2019
rev ($mm)
$4,733.31
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
$1,096.97
Employees
0
  • drill down
  • watch
Ticker: NYSE:APO
 
 
 
 
 
 
 
 
Apollo Global Management
Apollo Global Management
Apollo Global Management, LLC and its subsidiaries is a leading global alternative investment manager. They are contrarian, value-oriented investors in private equity, credit and real estate, with significant distressed expertise.
year
2019
rev ($mm)
$2,833.48
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
$843.19
Employees
0
  • drill down
  • watch
Ticker: RTOBF
 
 
 
 
 
 
 
 
Ratos AB
Ratos AB
Ratos is a private equity company that invests in Nordic companies where their core expertise as a professional, active and responsible owner over time creates good value growth. Added value is created in connection with acquisition, development and divestment of these primarily unlisted companies.
year
2019
rev ($mm)
$2,530.41
EBITDA ($mm)
$141.89
EBIT ($mm)
$80.55
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: SIVB
 
 
 
 
 
 
 
 
Silicon Valley Bank
Silicon Valley Bank helps innovative companies and their investors move bold ideas forward, fast. They provide a full range of financial services to companies of all sizes in innovation centers around the world.
year
2018
rev ($mm)
$2,387.31
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
$824.79
Employees
2836
  • drill down
  • watch
Ticker: BX
 
 
 
 
 
 
 
 
Blackstone Group LP
Blackstone Group LP
Blackstone is one of the world’s leading investment firms. They seek to create positive economic impact and long-term value for their investors, the companies they invest in, and the communities in which they work. They use extraordinary people and flexible capital to help companies solve problems.
year
2020
rev ($mm)
$1,913.85
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
$501.89
Employees
0
  • drill down
  • watch
Ticker: CG
 
 
 
 
 
 
 
 
Carlyle Group
Carlyle Group
The Carlyle Group is a global alternative asset manager with $193 billion of assets under management across 128 funds and 159 fund of funds vehicles as of June 30, 2015. Carlyle’s purpose is to invest wisely and create value on behalf of its investors, many of whom are public pensions.
year
2020
rev ($mm)
$1,544.30
EBITDA ($mm)
$357.20
EBIT ($mm)
$293.80
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Oaktree Capital Management, LLC
Oaktree Capital Management, LLC
Oaktree is a leader among global investment managers specializing in alternative investments. They emphasize an opportunistic, value-oriented and risk-controlled approach to investments in distressed debt, corporate debt, control investing, convertible securities, real estate and listed equities.
year
2019
rev ($mm)
$1,315.17
EBITDA ($mm)
$357.51
EBIT ($mm)
$331.49
Net Income ($mm)
$224.77
Employees
0
  • drill down
  • watch
Ticker: TSX:ONEX
 
 
 
 
 
 
 
 
Onex Corporation
Onex Corporation
Founded in 1984, Onex is one of the oldest and most successful private equity firms. They acquire and build high-quality businesses in partnership with talented management teams. They also invest in non-investment grade debt through credit funds and collateralized loan obligations.
year
2019
rev ($mm)
$1,081.00
EBITDA ($mm)
$857.00
EBIT ($mm)
$822.00
Net Income ($mm)
$4,277.00
Employees
0
  • drill down
  • watch
Ticker: COWN
 
 
 
 
 
 
 
 
Cowen Group, Inc.
Cowen Group, Inc.
Cowen Inc. is a diversified financial services firm that operates through two business segments: a broker dealer and an investment management division. Cowen Inc. focuses on delivering value-added capabilities to their clients in order to help them outperform.
year
2019
rev ($mm)
$865.94
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
$36.16
Employees
0
  • drill down
  • watch
Ticker: EQT
 
 
 
 
 
 
 
 
EQT AB
EQT AB
EQT is a leading Swedish investment firm with more than EUR 61B in raised capital across 29 funds and around EUR 40B in assets under management. EQT funds have portfolio companies in Europe, Asia and the US with total sales of more than EUR 19B and approximately 110,000 employees.
year
2019
rev ($mm)
$670.81
EBITDA ($mm)
$215.55
EBIT ($mm)
$199.55
Net Income ($mm)
$178.52
Employees
0
  • drill down
  • watch
Ticker: PSEC
 
 
 
 
 
 
 
 
Prospect Capital Corporation
Prospect Capital Corporation is a business development company that operates as a closed-end, non-diversified investment company that lends to and invests in energy-related businesses.
year
2013
rev ($mm)
$625.80
EBITDA ($mm)
EBIT ($mm)
$433.31
Net Income ($mm)
$292.38
Employees
  • drill down
  • watch
Ticker: TGOPF
 
 
 
 
 
 
 
 
3i Group Plc
3i Group Plc
3i Group plc is a multinational private equity and venture capital company headquartered in London, United Kingdom. It has offices in 13 countries across the Americas, Asia and Europe and had total assets under management of £10.5 billion as at 31 March 2012.
year
2020
rev ($mm)
$403.39
EBITDA ($mm)
$256.93
EBIT ($mm)
$253.21
Net Income ($mm)
$265.62
Employees
0
  • drill down
  • watch
Ticker: ENXTPA:FIM
 
 
 
 
 
 
 
 
Fimalac SA
Fimalac SA
Fimalac is a diversified holding company, listed on the Paris Stock Exchange, founded and managed by Marc Ladreit de Lacharrière. Fimalac Group is engaged in private equity, digital media, live shows and hotels and recreation.
year
2016
rev ($mm)
$392.72
EBITDA ($mm)
($13.56)
EBIT ($mm)
($54.12)
Net Income ($mm)
$68.47
Employees
2911
  • drill down
  • watch
Ticker: GIMB
 
 
 
 
 
 
 
 
Gimv
Gimv
Gimv is a European investment company with over three decades of experience in private equity and venture capital. Gimv currently manages around EUR 1.8 billion (including co-investment partnerships) of investments in about 50 portfolio companies.
year
2018
rev ($mm)
$244.30
EBITDA ($mm)
$205.78
EBIT ($mm)
$204.62
Net Income ($mm)
$119.37
Employees
0
  • drill down
  • watch
Ticker: MAIN
 
 
 
 
 
 
 
 
Main Street Capital Corporation
Main Street Capital Corporation
Main Street Capital Corporation is a principal investment firm that provides long-term debt and equity capital to lower middle market companies and debt capital to middle market companies.
year
2020
rev ($mm)
$238.16
EBITDA ($mm)
EBIT ($mm)
$205.20
Net Income ($mm)
Employees
0
  • drill down
  • watch